Gambia vs Niger: Tuberculosis patients living with HIV receiving antiretroviral therapy
Gambia
231 patients
in 2021
Niger
223 patients
in 2021
Gambia rank
65th
Niger rank
66th
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Gambia
- Niger
How they compare
Gambia currently reports 231 patients against 223 patients in Niger, a difference of 8 patients.
The two have swapped places 4 times across 15 shared years of data; in 2006 it was Gambia ahead.
Gambia ranks 65th and Niger ranks 66th of 183 countries.
Across the 3 decades both report, Gambia averaged higher in 2 and Niger in 1.
Head to head by decade
| Decade | Gambia | Niger | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.5 patients | 0 patients | 30.5 patients | Gambia |
| 2010s | 197.44 patients | 224.22 patients | 26.78 patients | Niger |
| 2020s | 275.5 patients | 247 patients | 28.5 patients | Gambia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Gambia or Niger?
- Gambia, at 231 patients against 223 patients in Niger as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Gambia and Niger?
- 8 patients, with Gambia ahead.
- How many years of comparable data are there for Gambia and Niger?
- 15 years are reported by both, from 2006 to 2021.
- How do Gambia and Niger rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Gambia ranks 65th and Niger ranks 66th of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.